Engineering E. coli strains using antibiotic-resistance-gene-free plasmids
Cell Reports Methods · 2023-12 · 3 (12) · 100669
DOI: 10.1016/j.crmeth.2023.100669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports Methods, 2023-12. Verfasst von Matthew B Amrofell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCCIH NIH HHS, NIH, USDA.
Abstract (Originalsprache)
We created a generalizable pipeline for antibiotic-resistance-gene-free plasmid (ARGFP)-based cloning using a dual auxotrophic- and essential-gene-based selection strategy. We use auxotrophic selection to construct plasmids in engineered E. coli DH10B cloning strains and both auxotrophic- and essential-gene-based selection to (1) select for recombinant strains and (2) maintain a plasmid in E. coli Nissle 1917, a common chassis for engineered probiotic applications, and E. coli MG1655, the laboratory "wild-type" E. coli strain. We show that our approach has comparable efficiency to that of antibiotic-resistance-gene-based cloning. We also show that the double-knockout Nissle and MG1655 strains are simple to transform with plasmids of interest. Notably, we show that the engineered Nissle strains are amenable to long-term plasmid maintenance in repeated culturing as well as in the mouse gut, demonstrating the potential for broad applications while minimizing the risk of antibiotic resistance spread via horizontal gene transfer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA.
- Department of Medicine, Division of Dermatology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington Univer…
- Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; The Edison Family Center for Genome Sciences & Systems Biology, Wa…
- Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA; Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO…
Förderung
- NCCIH NIH HHS
- NIH
- USDA
- National Center for Complementary and Integrative Health
- NSF
- National Science Foundation
- EPA
Zitieren
APA
Amrofell, M. B., Rengarajan, S., Vo, S. T., Ramirez Tovar, E. S., LoBello, L., Dantas, G., & Moon, T. S. (2023). Engineering E. coli strains using antibiotic-resistance-gene-free plasmids. Cell Reports Methods, 3(12), 100669. https://doi.org/10.1016/j.crmeth.2023.100669
Vancouver
Amrofell MB, Rengarajan S, Vo ST, Ramirez Tovar ES, LoBello L, Dantas G, et al. Engineering E. coli strains using antibiotic-resistance-gene-free plasmids. Cell Reports Methods. 2023;3(12):100669. doi:10.1016/j.crmeth.2023.100669
BibTeX
@article{Amrofell2023,
author = {Amrofell, Matthew B and Rengarajan, Sunaina and Vo, Steven T and Ramirez Tovar, Erick S and LoBello, Larissa and Dantas, Gautam and Moon, Tae Seok},
title = {Engineering E. coli strains using antibiotic-resistance-gene-free plasmids},
journal = {Cell Reports Methods},
year = {2023},
volume = {3},
number = {12},
pages = {100669},
doi = {10.1016/j.crmeth.2023.100669}
}
EUVIMED